Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-23-026275

President, R&D sold 1,383 shares at $11.16 ($15,434)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bergstrom Donald A President, R&D 2023-04-28 Sale −1,383 $11.16 $15,434 242,701 D: show line 1 in the form
Open-market sales · 1,383 sh · avg $11.16 · $15,434
Loading xslF345X04/doc4.xml…